{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:08:15Z","timestamp":1791101295077,"version":"4.1.0"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,1]]},"abstract":"<jats:p>OBJECTIVE. Increased intracerebral blood velocity measured by transcranial Doppler scanning identifies children with sickle cell anemia who are at increased risk of stroke. We have tried to develop an index based on routine clinical measurements that also predicts increased intracerebral blood flow.<\/jats:p>\n               <jats:p>METHOD. Routinely collected clinical and laboratory data were correlated with transcranial Doppler measurements on children with sickle cell anemia seen in a single institution in 2006. The index produced was validated on a second independent data set from children with sickle cell anemia.<\/jats:p>\n               <jats:p>RESULTS. The time-averaged mean of the maximum velocity in centimeters per second in the middle cerebral artery circulation correlated significantly with age, hemoglobin, lactate dehydrogenase, and aspartate transaminase levels, white blood cell count, and creatinine level. On multiple regression, hemoglobin and aspartate transaminase levels maintained their significance, whereas age had borderline significance, and an index was developed linked to a time-averaged mean of the maximum velocity of 220 \u2212 (8 \u00d7 hemoglobin) \u2212 (1.4 \u00d7 age) + (0.4 \u00d7 aspartate transaminase). This detected a time-averaged mean of the maximum velocity of &amp;gt;170 cm\/second with 100% sensitivity and 58% specificity. The index was validated on the second data set and again showed 100% sensitivity with 73% specificity.<\/jats:p>\n               <jats:p>CONCLUSION. This simple index has the potential to identify children who are at higher risk of cerebrovascular disease to allow them to be prioritized for transcranial Doppler scanning and other intracerebral imaging.<\/jats:p>","DOI":"10.1542\/peds.2007-2771","type":"journal-article","created":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T00:27:14Z","timestamp":1211243234000},"page":"e1628-e1632","source":"Crossref","is-referenced-by-count":36,"title":["A Simple Index Using Age, Hemoglobin, and Aspartate Transaminase Predicts Increased Intracerebral Blood Velocity as Measured by Transcranial Doppler Scanning in Children With Sickle Cell Anemia"],"prefix":"10.1542","volume":"121","author":[{"given":"David C.","family":"Rees","sequence":"first","affiliation":[{"name":"Department of Paediatric Haematology, King's College School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira C.","family":"Dick","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, King's College School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue E.","family":"Height","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, King's College School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"O'Driscoll","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology, King's College School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.E.","family":"Pohl","sequence":"additional","affiliation":[{"name":"Vascular Laboratory, King's College Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Goss","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Evelina Children's Hospital, Guy's and St Thomas' Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R.","family":"Deane","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Evelina Children's Hospital, Guy's and St Thomas' Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,6,1]]},"reference":[{"key":"2021120905453581000_R1","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cooperative study of sickle cell disease: cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood.\u20081998;91(1):288\u2013294"},{"key":"2021120905453581000_R2","doi-asserted-by":"crossref","unstructured":"Adams RJ, McKie VC, Nichols FT, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med.\u20081992;326(9):605\u2013610","DOI":"10.1056\/NEJM199202273260905"},{"key":"2021120905453581000_R3","doi-asserted-by":"crossref","unstructured":"Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med.\u20081998;339(1):5\u201311","DOI":"10.1056\/NEJM199807023390102"},{"key":"2021120905453581000_R4","unstructured":"NHS Sickle Cell and Thalassaemia Screening Programme. Sickle Cell Disease in Childhood. Standards and Guidelines for Clinical Care. London, United Kingdom: NHS Sickle Cell and Thalassaemia Screening Programme; 2006"},{"key":"2021120905453581000_R5","doi-asserted-by":"crossref","unstructured":"Fullerton HJ, Adams RJ, Zhao S, Johnston SC. Declining stroke rates in Californian children with sickle cell disease. Blood.\u20082004;104(2):336\u2013339","DOI":"10.1182\/blood-2004-02-0636"},{"key":"2021120905453581000_R6","doi-asserted-by":"crossref","unstructured":"Fullerton HJ, Gardner M, Adams RJ, Lo LC, Johnston SC. Obstacles to primary stroke prevention in children with sickle cell disease. Neurology.\u20082006;67(6):1098\u20131099","DOI":"10.1212\/01.wnl.0000237398.13545.86"},{"key":"2021120905453581000_R7","doi-asserted-by":"crossref","unstructured":"Makani J, Williams TN, Marsh K. Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol.\u20082007;101(1):3\u201314","DOI":"10.1179\/136485907X154638"},{"key":"2021120905453581000_R8","doi-asserted-by":"crossref","unstructured":"Neely CL, Wajima T, Kraus AP, Diggs LW, Barreras L. Lactate dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease. Am J Clin Pathol.\u20081969;52(2):167\u2013169","DOI":"10.1093\/ajcp\/52.2.167"},{"key":"2021120905453581000_R9","doi-asserted-by":"crossref","unstructured":"Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med.\u20082004;350(9):886\u2013895","DOI":"10.1056\/NEJMoa035477"},{"key":"2021120905453581000_R10","doi-asserted-by":"crossref","unstructured":"Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood.\u20082006;107(6):2279\u20132285","DOI":"10.1182\/blood-2005-06-2373"},{"key":"2021120905453581000_R11","doi-asserted-by":"crossref","unstructured":"Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med.\u20082002;8(12):1383\u20131389","DOI":"10.1038\/nm1202-799"},{"key":"2021120905453581000_R12","unstructured":"Aliyu ZY, Tumblin AR, Kato GJ. Current therapy of sickle cell disease. Haematologica.\u20082006;91(1):7\u201310"},{"key":"2021120905453581000_R13","unstructured":"Derchi G, Forni GL, Formisano F, et al. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies. Haematologica.\u20082005;90(4):452\u2013458"},{"key":"2021120905453581000_R14","doi-asserted-by":"crossref","unstructured":"Neish AS, Blews DE, Simms CA, Merritt RK, Spinks AJ. Screening for stroke in sickle cell anemia: comparison of transcranial Doppler imaging and nonimaging US techniques. Radiology.\u20082002;222(3):709\u2013714","DOI":"10.1148\/radiol.2223010524"},{"key":"2021120905453581000_R15","doi-asserted-by":"crossref","unstructured":"Bulas DI, Jones A, Seibert JJ, Driscoll C, O'Donnell R, Adams RJ. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol.\u20082000;30(11):733\u2013738","DOI":"10.1007\/s002470000317"},{"key":"2021120905453581000_R16","doi-asserted-by":"crossref","unstructured":"Hogan AM, Kirkham FJ, Prengler M, et al. An exploratory study of physiological correlates of neurodevelopmental delay in infants with sickle cell anaemia. Br J Haematol.\u20082006;132(1):99\u2013107","DOI":"10.1111\/j.1365-2141.2005.05828.x"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/6\/e1628\/1122554\/zpe006080e1628.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/6\/e1628\/1122554\/zpe006080e1628.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T23:29:08Z","timestamp":1639092548000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/6\/e1628\/72747\/A-Simple-Index-Using-Age-Hemoglobin-and-Aspartate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,1]]},"references-count":16,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2008,6,1]]},"published-print":{"date-parts":[[2008,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-2771","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,1]]}}}